Jobs
View more job listings or post a job
Bioduro-Sundia Associate Director/Director in Laboratory Animal and Exploratory Toxicology
Variant Bio (Senior) Scientist - DMPK
Alturas Analytics Scientist 1
University of California, Davis TOXICOLOGY ANALYTICAL CHEMIST (STAFF RESEARCH ASSOCIATE 3)
University of California, Davis CALIFORNIA ANIMAL HEALTH AND FOOD SAFETY LABORATORY - TOXICOLOGY LAB RESEARCH SUPERVISOR/GROUP LEADER
Eli Lilly and Company R-39973 Scientific Director ADME - Novel Modalities (Open)
FibroGen Director DMPK
Applied BioMath Technical Marketing Specialist
Horizon Therapeutics Director, Bioanalytical Sciences
Exelixis Principal Scientist - DMPK
Post a job

Symposium

[Free Online Symposium] Promising Biotech Startups: Their Science and Stories


Speakers: Darren Cooke, Life Sciences Entrepreneurship Center, UC Berkeley; Sam Lai, Inhalon; Sigi Neerken, InnoSIGN; Scott Shively, Bexion; Angela Lai, Betteromics; Robert Li, LTZ Therapeutics; Matthew O'Connor, Cyclarity; Cindy McReynolds, EicOsis
Organizers: Toby Freedman PhD, Synapsis Search Recruiting; Shichang Miao PhD, Amgen; Donald McCarthy PhD, Samsara BioCapital; Elina Lavit, OncoNano Medicine Inc.
Date: 2023-02-06
Time: 8:30-13:30 Pacific Time
Registration fee: 0
Location: Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2023-02-03  (it will close sooner if the seating cap is reached)

About the Topic

Note: This is an online meeting, The Zoom link will be sent to the registrants 1+ days before the event.


About the Speakers

PST

EST

Topic

Presenter

8:30-8:40 am

11:30-11:40 am

Welcome Remarks

Shichang Miao

8:40-9:15 am

11:40-12:15 pm

InnoSIGN: Revolutionize precision medicine through OncoSIGNal pathway activity profiling

Sigi Neerken, PhD, Co-founder and Chief Business Officer, InnoSIGN

9:15-9:50 am

12:15-12:50 pm

The role of angel investors and startup accelerators in the life sciences startup and fundraising ecosystem

Darren Cooke, JD. Executive Director, Life Sciences Entrepreneurship Center, UC Berkeley

9:50-10:25 am

12:50-1:25 pm

Bexion Pharmaceuticals: Leveraging biologic immunotherapy to treat solid tumor cancers

Scott Shively, CEO & President, BexionPharmaceuticals, Inc.

10:25-10:35 am

1:25-1:35 pm

Break

-

10:35-11:10 am

1:35-2:10 pm

Betteromics: A data operating system for the modern life science enterprise

Angela Lai, CEO, Betteromics Inc.

11:10-11:45 am

2:10-2:45 pm

LTZ Therapeutics: Lift to Zenith with novel immunotherapies

Robert Li, PhD, Co-founder & CEO, LTZ Therapeutics

11:45-12:20 pm

2:45-3:20 pm

Cyclarity Therapeutics: Targeting oxidized cholesterol to reverse atherosclerosis: a new drug and a new paradigm

Matthew O’Connor, Ph.D., Co-CEO, CyclarityTherapeutics

12:20-12:55 pm

3:20-3:55 pm

EicOsis: From horses to humans: Identification of a novel drug target, the soluble epoxide hydrolase, for the treatment of pain and chronic inflammation

Cindy McReynolds, PhD, CEO, EicOsis

12:55-1:30 pm

3:55-4:30 pm

TBD

Sam Lai, Founder / CSO, Inhalon

1:30-2:00 pm

4:30-5:00 pm

Panel Discussion

All Speakers


2024-04-12, [Free Online] Innovative Life Science Technologies in the Drug Development Toolbox: From Cancer Organoids and Biomarker Profiling to Label-Free Multiplex QES Assays
2024-04-26, [In-Person] Oncology Clinical Dose Optimization in Light of FDA Project Optimus
2024-05-06, [In-Person] Human Mass Balance and Metabolite Profiling Studies: Strategies, Technical Approaches, Regulatory Guidance, Applications and Case Studies
2024-05-13, [Free Online] Highlights of 2023 FDA Drug Approvals
2024-05-21, [In-Person] Nonclinical Safety Studies for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
2024-05-30, [Online Workshop] Career Transition for Research Scientists
2024-06-13, [In-Person] CMC Strategies and Activities for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
2024-06-20, Alzheimer's Disease: untangling what we thought we knew and future Precision Medicine Diagnostics and Therapeutics
2024-09-10, [In-Person] Rethinking Translational PK/PD and Human Dose Projections for Novel Therapeutic Modalities: Covalent Inhibitors, PROTACs, Molecular Glues, ADCs, Ocular and Neuro delivery, Vaccines, Bispecifics, Cell and Gene Therapies
2024-09-20, [In-Person] Non-clinical safety assessments of biologics and novel modalities for IND/NDA Filing: Nuts, Bolts and Best Practices
2024-10-10, [In-Person] Regulatory Global Submission: Strategies and Best Practices for FDA, EMA and PMDA
©Pharmaceutical & BioScience Society, International; Last Modified: 3/28/2024; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Lena Biosciences Predictive toxicology. Mitochondrial toxicity in a drug metabolism-competent model with active transporters. Intrinsic & idiosyncratic DILI.
Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Submit a Text Ad